Why better customer data is critical to improving HCP engagement

4 April 2017
guillaume_roussel_large-1-

As the life sciences industry seeks to improve customer engagements through personalized multichannel communications, the need for quality customer data is greater than ever, writes Guillaume Roussel, director of strategy for Veeva Open Data, Europe, part of the life sciences software provider Veeva Systems, in an expert view piece.

Reliable customer data has long been integral to effective commercial execution within life sciences. For field teams, access to accurate and up-to-data customer data ensures they remain compliant and productive. For reps, successful calls rest on their ability to access complete healthcare professional (HCP) information, such as demographics and specialty.

But across the industry, customer data quality is a widespread concern. In fact, 87% of companies surveyed in the 2016 Veeva European Customer Data Survey, say they face customer data quality challenges. Sales reps often have wrong addresses, don’t know which HCPs to contact, or have outdated data about specialty.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical